Skip to main content
. 2017 Oct 10;8(61):103640–103656. doi: 10.18632/oncotarget.21760

Figure 6. Stem cell tracking revealed trapping of iPS-MSCs in the lungs after intravenous injection.

Figure 6

(A) Representative agarose gels showing the expression of human POLR2E and FN mRNA in mouse heart, liver, spleen, lung, and right kidney by using specific primers. Data were representatives of 3 mice from each time point. (B) RT-PCR showing human FN mRNA expression in mouse left kidney at four different time points after iPS-MSC injection. Numbers (1-2) indicate individual mouse in a given group. (C) In vivo imaging of NOD/SCID mice. Mice were injected with unlabeled iPS-MSCs (left) or DiR-labeled iPS-MSCs (right).